PIPEs
KKR to buy Life Healthcare stake in India hospital JV
KKR has agreed to pay INR4.3 billion ($59.6 million) to South African hospital chain Life Healthcare Group for its stake in Max Healthcare, a hospital operator that it owns through a joint venture with Max India.
Silver Lake to invest $600m in Wanda-owned cinema chain
Silver Lake has invested $600 million in AMC Entertainment Holdings, a US cinema chain owned by Dalian Wanda Group, a once acquisitive Chinese conglomerate now said to be retreating from overseas markets.
Baring Asia to invest $538m in Japan's Pioneer
Baring Private Equity Asia has agreed to invest up to JPY60 billion ($538 million) in Pioneer Corp, by subscribing to a new share issue by the struggling Japanese conglomerate.
GPs support $590m investment in take-private target China Biologic
China Biologic Products, a US-listed biopharmaceuticals player that was subject to two take-private offers, said it was set to raise $590 million by issuing new shares to investors including Centurium Capital, CITIC Capital, and Hillhouse Capital.
Boulevard Capital invests $20m in Singapore's Stratech
Boulevard Capital Partners, a private equity investor focused on infrastructure including telecom towers, has agreed to invest $20 million in Singapore-listed surveillance technology specialist Stratech.
Blackstone to invest $400m in Hong Kong-listed HEC Pharm
The Blackstone Group has agreed to invest $400 million in YiChang HEC Changjiang Pharmaceutical (HEC Pharm), a Chinese drug developer listed in Hong Kong, through a convertible bond issuance.
Deal focus: L Catterton taps the China luxury story
L Catterton Asia aims to help Chinese online luxury goods retailer Secoo expand its frontiers with technological and logistical support from e-commerce giant JD.com
L Catterton, JD to invest $175m in China’s Secoo
L Catterton Asia and Chinese online retailer JD.com have agreed to invest $175 million in Secoo, a Chinese e-commerce platform for luxury goods that is listed in the US.
Vivo, Advantech invest $87m in Sinovac as take-private is abandoned
Vivo Capital and Advantech Capital have committed $86.73 million to Chinese biopharmaceutical player Sinovac Biotech. Both investors were members of a consortium that was bidding to privatize the US-listed company, but that process has been terminated.
Ant Financial leads $321m round for China's Hellobike
Ant Financial, Alibaba Group’s financial services affiliate, has led a RMB2.1 billion ($321 million) investment in Youon Bike, the listed parent of China-based bike-sharing operator Hellobike.
Hony sells Chinese hospital to Hong Kong-listed platform
Hony Capital has agreed to sell three private hospitals in Zhejiang province to Hospital Corporation of China (HCC), a Hong Kong-listed platform it established several years ago, for RMB630 million ($98 million).
Chinese state-backed PE fund anchors Foxconn IPO
A private equity fund backed by China’s State Development & Investment Corporation (SDIC) is the largest strategic investor in the RMB27.1 billion ($4.3 billion) Shanghai IPO of a Foxconn Technology Group manufacturing unit.
CDH, DCP to invest $70m in China's Sunpower
DCP Capital Partners, a private equity firm established by the former China heads of KKR, has agreed to jointly invest $70 million alongside CDH Investments in Chinese energy industry supplier Sunpower.
L Catterton to invest $125m in India's FLF - update
L Catterton Asia will purchase an approximately 10% stake in India-listed integrated fashion retailer Future Lifestyle Fashion (FLF) for INR8.5 billion ($125 million) through newly issued shares and secondary purchases.
China Everbright fund to buy stake in LifeTech Scientific
A healthcare fund managed by China Everbright has agreed to acquire the bulk of global medical equipment manufacturer Medtronic’s stake in Hong Kong-listed LifeTech Scientific Corporation.
PE-backed Sunlands completes $149m US IPO
Private equity-backed Sunlands Online Education ended its first day of trading on the New York Stock Exchange marginally below its IPO price following a $149.5 million offering.
Sailing invests $30.6m in China-US biopharma player
Sailing Capital has invested $30.6 million in Cellular Biomedicine Group (CBMG), a China and US-based biopharmaceutical company focused on immunotherapy cancer treatments.
Creador invests in Vietnam's Mobile World
Creador has completed its first investment in Vietnam, committing VND994 billion ($43.8 million) to Mobile World, the country’s leading mobile device and consumer electronics retailer.
KKR joins $1.75b investment in India's HDFC
KKR has joined a group of investors including Singapore’s GIC Private and the Ontario Municipal Employees Retirement System (OMERS) to commit INR111 billion ($1.75 billion) to listed Indian financial institution HDFC.
CITIC Capital takes majority control of Harbin Pharmaceutical
CITIC Capital has increased its stake in Harbin Pharmaceutical Group to 60.86%, becoming the controlling shareholder of the Chinese state-backed business in which it has been an investor since 2005.
China semiconductor fund agrees to invest $400m in local chip maker
State-backed private equity investor China Integrated Circuit Industry Investment Fund (IC Fund) has agreed to buy an approximately 19% stake in domestic computer chip maker Hua Hong Semiconductor for $400 million.
OrbiMed re-ups in India's Vivimed Labs
OrbiMed has invested a further $7.5 million in the active pharmaceutical ingredient (API) unit of India-listed drug maker Vivimed Labs.
Hony to invest in Li & Fung consumer assets
Hony Capital has agreed to invest in several businesses – covering furniture, beauty, and apparel – from Hong Kong conglomerate Li & Fung for $1.1 billion.
Creador invests $33m in India’s Ujjivan
Creador has invested INR2.15 billion ($32.9 million) in Ujjivan Financial Services, the publicly listed holding company for Ujjivan Small Finance Bank.
